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Abstract 
Breast cancer is a significant public health problem since it affects l 
out of every 8 women in the United States (Jernal, Thomas, Murray, & 
Thun, 2002). Many risk fuctors for breast cancer have been extensively 
studied in the past 25 years and the presence of these risk factors can 
greatly increase a woman's chance of developing breast cancer. A family 
history ofbreast cancer can increase an individual's risk by 1.5 to 3.0 
times (Ottman, King, Pike, eta!., 1983). The presence of a BRCAl 
mutation is associated with an 87% cumulative risk by the age of70 and 
BRCA2 mutations are associated with an 84% cumulative risk ofbreast 
cancer by age 80 (Ford, Easton, Stratton, et a!., 1998). Breast cancer risk 
assessment models have been developed as a result of the knowledge 
gained from epidemiological studies. These models can provide more 
accurate estimates of lifetime risks for the development of breast cancer. 
Oftentimes, a woman's perceived risk of breast cancer is significantly 
different than her objective risk and this can impact on the adherence to 
breast cancer screening measures. A brief review of the literature on 
breast cancer risk perception and adherence to screening measures is 
provided in this paper. Additionally, a small pilot study addressing risk 
perception, objective risk and adherence to screening measures is 
described. The women in this study were attending a high-risk cancer 
clinic because of family histories of breast cancer. Finally, some 
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suggestions are made about strategies that may be effective for improving 
women's breast cancer risk perception. 
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Introduction 
In the year 2002, breast cancer will remain the number one cause of 
cancer in women (excluding non-melanoma skin cancers) within the 
United States. Breast cancer is expected to account for 31% of new cases 
of cancer this year (Jemal, Thomas, Murray, & Thun, 2002). Estimated 
deaths from breast cancer this year are 15% of all cancer deaths, making it 
the second leading cause of cancer death in women. Only lung cancer 
deaths are expected to surpass breast cancer deaths in women this year. 
Approximately 25% of all cancer deaths are expected to be due to lung 
cancer. What can be derived from the statistics is that breast cancer is not 
an uncommon disease and in fact, breast cancer affects 1 out of every 8 I women in the United States (Jemal, et a!., 2002). This is based on a 
woman's lifetime probability, from birth to death. For many women this 
risk is even higher and it is based on a multitude of factors. Over the past 
twenty-five years, epidemiological studies of breast cancer have yielded 
crucial information about the factors that may predispose women to this 
disease. These risk factors include age, and family history ofbreast, 
ovarian, or prostate cancer, prior radiation to the chest, an abnormal breast 
biopsy, personal history of breast, ovarian and/or endometrial cancer, 
reproductive history, and the presence ofBRCA1 or BRCA2 genetic 
mutations. Epidemiological studies are also contributing knowledge on 
other possible risk factors, such as diet, alcohol consumption, cigarette 
smoking, and physical activity. 
Results oflarge epidemiological studies focused on many of the above 
risk factors and have provided researchers and clinicians with a framework 
for assessing breast cancer risk. There are now four different risk models 
that clinicians can use to predict breast cancer risk (Armstrong, Eisen, & 
Weber, 2000). Two of the risk models are specific for women who have 
either a mother or sister with breast cancer and are used primarily for 
genetic counseling purposes. It is important to know which women may 
l_ 
be at higher risk for the development ofbreast cancer because prevention 
and screening measures may be different for them than for women at 
average risk. For example, clinicians, along with their patients, can 
devise individualized management strategies based on the patient's I personal risk of developing breast cancer. This could include 
mammography starting at an earlier age, more frequent mammograms and 
clinical breast exams, prophylactic mastectomy and/or oophorectomy, 
chemoprevention, and, possibly, lifestyle changes. 
A person's perception of the risk, or susceptibility to developing a 
disease, has been found to be a strong predictor of preventive health 
behaviors (Strecher & Rosenstock, 1997). Additionally, perception of risk 
may alter psychological adjustment. For many women, the thought of 
developing breast cancer can evoke fear and grave concern. This is 
especially true for women who are at high risk for developing breast 
cancer based on a positive family history of the disease. A review by 
Lerman and Schwartz (1993) revealed two findings across studies of high-
2 
risk women: first, these women had high levels of psychological distress 
due to worries about developing breast cancer, and second, despite their 
elevated risk and worries about breast cancer, they often did not adhere to 
cancer screening guidelines. In contrast to the above, several other studies 
found a positive association between psychological distress and adherence 
to screening measures. Another study has shown that women at high risk 
overestimated their actual risk, which led to higher anxiety and a low 
performance ofbreast self-examination (Gagnon, et al., 1996). 
The purpose of this paper is threefold. The first is to provide an 
overview of risk factors for breast cancer and risk factor assessment • 
I models, as well as provide a review of the literature on breast cancer risk perception. The third is to describe a small pilot-study focused on personal 
breast cancer risk perception, objective risk and screening behaviors. As 
part of the study, qualitative data on personal risk perceptions were 
compared to quantitative data derived from breast cancer risk models. 
Breast Cancer Risk Factors 
Age and Family History 
There are many factors associated with an increased risk of breast 
cancer. One uncontrollable risk factor is age. In the general population, 
the lifetime probability of developing breast cancer in a female is 
approximately 12% (Jemal, et al., 2002). From birth to age 39, the 
probability of developing breast cancer is only 0.44%; from ages 40 to 49, 
the probability increases to 4.17%; and in the age group 60 to 79, the 
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probability rises to 7.14% (Jemal, et al., 2002). Next to age, family 
history is the most significant risk factor. We currently know of two 
different types ofhreast cancer risk related to family history. For the 
majority of women with a family history of breast cancer, the disease in 
the family member is probably not related to a germline mutation in 
a tumor-suppressor gene. The risk of developing breast cancer in women 
who do not have a germline mutation in a tumor-suppressor gene, but do 
have a first-degree relative (mother or sister) with a history of breast 
cancer, is increased by 1.5 to 3.0 times (Ottman, Pike, King, & Hendersen, k 
-
1983). Anderson and Badzioch (1993) found that breast cancer risks were 
I 2.7-fold higher in families with prostate, endometrial, or ovarian cancers, than in families without these diseases. Interestingly, these risks increased 
6- to 8-fold when there were two or more cases of prostate cancer in the 
family. True inherited breast cancer, which is a result of a germline 
mutation, accounts for approximately 7% of breast cancer cases (Claus, 
Schildkraut, Thompson, & Risch, 1996). The majority of these hereditary 
breast cancers are associated with two high-penetrance breast cancer 
susceptibility genes, BRCAl and BRCA2 (Ford, Easton, Stratton, et. al, 
1998). The frequency of these two genes may be higher in certain 
populations, such as in Ashkenazi Jews (Easton, Ford, & Bishop, 1995). 
It has been estimated that BRCAl mutations are associated with an 87% 
cumulative risk ofbreast cancer by age 70 and BRCA2 mutations are 
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associated with an 84% cumulative risk of breast cancer by age 80 (Ford, 
et al. 1998). These mutations are also associated with earlier age of breast 
cancer onset, a high risk of contralateral breast cancer, high risk of ovarian 
cancer, and a higher than average risk of prostate cancer in men and 
pancreatic cancer in men and women (American Medical Association, 
2001). 
Hormonal Factors 
Hormones are related to breast cancer occurrence with many studies 
showing associations with early age of menarche, late age of menopause, 
and nulliparity. In a review by MacMahon, Cole, and Brown (1973), it 
appears that there is a 20% decrease in breast cancer risk for each year that 
menarche is delayed. For women who begin menopause before age 45, 
there is a 50% reduction in risk for breast cancer compared to women 
whose menopause occurs after age 55 (Trichopoulos, MacMahon, & Cole, 
1972). Nulliparous women have a higher risk of breast cancer than do 
parous women. Also, women who have their first full-term pregnancy 
after age 30 are at higher risk for breast cancer (2- to 5-fold increase) than 
women who have had a first full-term pregnancy by age 19 (Trichopoulos, 
Hsieh, & MacMahon, 1983). To date, there is no clear evidence of a 
relationship between use of exogenous hormones (hormone replacement 
therapy or oral contraceptives) and breast cancer. However in one meta-
analysis of estrogen replacement therapy, there was a small but 
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statistically significant increase in the risk (RR 1.3) ofbreast cancer 
(Steinberg, Thacker, Smith, eta!, 1991). 
Benign Breast Disease 
Premalignant histologic changes in breast tissue can place a woman at 
higher risk for developing breast cancer. In fact, Dupont and Page (1985) 
showed that atypical hyperplasia on biopsy leads to a relative risk of 4 to 5 
for the development ofbreast cancer. This risk was found to be even 
greater if a woman had at least one first degree relative (i.e., mother or 
sister) with breast cancer. 
Environmental and Dietary Factors 
Although these risk factors are not accounted for in the risk models, 
they may still be important to consider when evaluating a woman's risk 
for breast cancer. The most important environmental factor that places a 
woman at high risk is exposure to ionizing radiation to the chest. Women, 
who have received mantle irradiation for Hodgkin's Lymphoma before the 
age of 15, have a markedly increased risk for breast cancer (Hancock, 
Tucker, & Hoppe, 1993). Studies on fat intake and breast cancer have 
been inconclusive thus far, but many studies of alcohol intake have 
suggested an association between breast cancer and moderate alcohol 
consumption (Greenwald & Hunter, 1999; Ellison, Zhang, McLennan, & 
Rothman, 2001). 
Breast Cancer Risk Assessment Models 
6 
Various breast cancer risk models have been developed in order to 
assist clinicians in evaluating an individual's personal risk for breast 
cancer. Many of these risk factors for breast cancer were descn"bed above 
and many of them may interact to increase breast cancer risk. An 
epidemiological and clinical challenge has been how to detennine risk 
based on a combination of risk factors. Several prediction models have 
been devised to address this issue. These prediction models are based on 
the risk factors that are most consistently associated with breast cancer. 
Thus, they do not include dietary and environmental risk factors that 
currently have shown inconclusive results in epidemiological studies. 
Although it is known that prior irradiation exposure to the chest is strongly 
associated with breast cancer, it is not included in the models because it is 
relatively rare in the general population. The three different risk models 
that will be described are The Gail Model, The Claus Model, and the 
BRCAPRO model. 
The Gail Model 
The Gail Model is the most widely used prediction model for women in 
the general population. It is a model of relative risks for various 
combinations of risk factors that was developed from the Breast Cancer 
Detection Demonstration Project, a large mammographic-screening 
program in the 1970's (Gail, eta!., 1989). Of particular note, this study 
involved only Caucasian women. After evaluating a number of risk 
factors, Gall, et a!. (1989) included the following risk fuctors in the model: 
7 
age at menarche, age at first live birth, number of previous breast biopsies, 
and number of first-degree relatives with breast cancer. Calculations of 
five-year and lifetime risks for breast cancer can be derived from this 
model. A software program, available from the National Cancer Institute, 
can be used for easy calculations ofbreast cancer risk (National Cancer 
Institute, n.d. ). 
The Claus Model 
Another commonly used risk prediction model was developed by 
Claus, Risch, and Thompson (1994). It is based on data from the Cancer 
and Steroid Hormone Study, which was a population-based, case-control 
study conducted by the Centers for Disease Control. This model is mostly 
based on family history of breast cancer and on assumptions of the 
prevalence ofhigh-penetrance genes for susceptibility of breast cancer. 
Information on family history, such as age at diagnosis in first- and 
second-degree (grandmothers or aunts) relatives breast cancer is 
incorporated into the model. Only a small number of non-Caucasian 
women were included in the study. Therefore, just as with the Gail 
Model, one must use caution when using these models for non-Caucasian 
women. 
The BRCAPRO Model 
A more recent model, by Parmigiani, Berry, and Aguilar (1998) 
computes the probability that an individual carries a germ-line mutation at 
BRCAl or BRCA2, on the basis of family history ofbreast cancer and 
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ovarian cancers. It is now well known that carriers of these inherited 
mutations are at a much higher risk for the development of breast and 
ovarian cancer. Some of the fumily-history risk factors for carrying a 
BRCA1 or BRCA2 mutation are outlined in Table 1. 
Table 1 
Risk Factors for Carrying a BRCAl or BRCA2 Mutation 
Known BRCAl or BRCA2 mutation in a family member 
Breast and ovarian cancer in the same individual 
Two or more family members with ovarian cancer or breast cancer before 
the age of 50 
Presence ofbi!ateral breast cancer 
Any male breast cancer in the family 
Early-onset breast cancer and Ashkenazi Jewish ancestry 
Ovarian cancer at any age and Ashkenazi Jewish ancestry 
Source: Armstrong, K., Eisen, A, & Weber, B. (2000). 
The BRCAPRO model is used as a tool by clinicians who offer genetic 
counseling, to determine whether an individual should pursue genetic 
testing. It is not designed to assess breast cancer risk in general, but 
instead is specific for women with family history risk factors. 
Prediction models: limitations 
The Gail and Claus models are both limited based on the variables that 
were chosen as risk fuctors. Both models excluded some well-established 
breast cancer risk factors such as family history of ovarian cancer and a 
family history of bilateral breast cancer. Furthermore, Gail and colleagues 
only included first-degree relatives with a history of breast cancer. 
Therefore, when an individual has a significant fumily history of breast 
cancer, it may be preferable to use the Claus model. The disadvantage of 
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both the Gail and Claus models in hereditary breast cancer is that they 
underestimate breast cancer risk in BRCAl and BRCA2 mutation carriers, 
and over-estimate risk for a woman from the same family who 
does not carry either of these mutations (Costantino, eta!., 1999). The 
BRCAPRO model can be used as a supplement when an individual's 
family history suggests that there may be an autosomal dominant 
inheritance. Typically it is only used if an individual has a strong family 
history of breast cancer and is interested in genetic susceptibility testing 
for the presence ofBRCAl and/or BRCA2. 
Perceived Risk of Breast Cancer and Adherence to Screening Measures-
A Review 
Results from previous studies have found both positive and negative 
associations between family history of breast cancer, high perceived risk 
and compliance with screening measures such as mammography, clinical 
breast exam (CBE), and breast self examination (BSE). In Rosenstock's 
article (1974), he states, "A person's perception of the risk of, or 
susceptibility to, developing a disease is believed to be an important 
determinant of his or her health-related behaviors" (p. 354). This is based 
on the Health Belief Model that is often used to guide research on the use 
of screening measures to detect illness. Researchers have used this model 
to examine factors associated with the use of mammography, CBE, and 
BSE. A recent study by Finney and Iannotti (200 I) expanded the use of 
the Health BeliefModel to include issue involvement with breast cancer 
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(i.e., the level of involvement with breast cancer fundraisers or other 
educational forums, degree of reading about breast cancer, etc.) and 
salience of breast cancer family history. Lipkus, Rimer, and Strigo (1996) 
have used the Transtheoretical Model to examine relationships among 
objective and subjective risk for breast cancer and mammography use. 
Other researchers have merely studied risk perception of breast cancer 
without applying the concept to any specific behavioral model. Several 
breast cancer risk perception studies will be reviewed more closely in the 
following sections. These particular studies were chosen because they 
addressed both perceived risk of breast cancer and adherence to screening 
measures. 
Psychological Distress and Surveillance Behaviors of Women with a 
Family History of Breast Cancer 
Kash, Holland, Halper, and Miller (1992) used the Health Belief Model 
to examine their hypothesis that women who perceived themselves as 
vulnerable to breast cancer, and who thought that the efficacy of early-
detection measures outweighed the barriers, would adhere to early-
detection measures more often than women who did not hold these same 
beliefs. Additionally, they used Fear Arousing Communication Theory to 
help determine whether women with a moderate level of anxiety would 
engage in screening measures more often than women with either low or 
high levels of anxiety related to breast cancer. Subjects were selected 
from an early detection program for women at high risk for breast cancer 
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seen at the Strang Cancer Prevention Center between January 1989 and 
September 1990. The program included a CBE, mammography, and 
instructions for BSE and follow-up visits scheduled every 6 months. 
Women had to have either two or more first-degree relatives with breast 
cancer, a first-degree relative with premenopausal breast cancer, or a 
mother and maternal grandmother with breast cancer to be eligible for the 
program. A total of217 (69%) women were included in the final study 
sample. The mean age of the women was 44 years, and the majority of 
them were white, college educated, and in professional or managerial 
positions. While these women were waiting for their medical visits, they 
were asked to complete a self-administered questionnaire that took 
between 30-45 minutes. The questions based on the Health Belief Model 
assessed perceived susceptibility to breast cancer, severity of disease, 
benefits and risks of interventions and obstacles to interventions. 
Preventive health behaviors were also assessed and the items ranged from 
general behaviors such as vitamin usage and dental visits to specific 
behaviors such as the practice ofBSE. In addition, several psychological 
scales were included that measured psychological symptoms, social 
support, and social desirability. 
Results from the questions about health beliefs revealed that 76% of 
these women felt they were at moderate to extreme risk for developing 
hreast cancer. Interestingly, only 24% felt their chances of developing 
hreast cancer were low to none at all, despite the fact that they chose to 
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attend the high-risk breast cancer program. Most of the women adhered to 
scheduled mammograms and CBE, but slightly less than half performed 
monthly BSE (see Table 2). Multiple regression analysis was used to 
reveal predictors for engaging in preventive health behaviors. Women 
who did not come for their mammograms as scheduled were found to be 
significantly more anxious (P<0.007). Lower cancer anxiety also resulted 
in better adherence to clinical breast exams and performance ofbreast 
self-examinations. Women who never performed BSE perceived 
themselves to be at higher risk for breast cancer in contrast to women who 
performed monthly BSE perceiving themselves as being at moderate risk 
(P<O.OS). The three significant predictors of preventive health behaviors 
were lower psychological distress (P<0.0004), lower perceived 
susceptibility (P<O.Ol ), and greater perceived personal efficacy in 
preventing breast cancer (P<0.04). 
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Table 2 
Percentages of Health Beliefs and Early Detection Methods Used by 
Women 
Health Beliefs and Early Detection Methods 
Breast cancer is a serious disease 
Ability to personally do something 
Perceived Susceptibility to Breast Cancer 
Very to extremely likely 
Moderately likely 
Low to none at all 
Scheduled mammograms 
Regular breast examinations 
Perform breast self-examination 
Monthly 
Not regularly 
Not at all 
Source: Kash, Holland, Halper, & Miller (1992). 
% 
>95 
>70 
41 
35 
24 
94 
69 
40 
50 
10 
Increased perceived susceptibility and personal efficacy predicted fewer 
general health care behaviors than would be supported by the Health 
Belief Model. The women who rated themselves as high on perceived risk 
and had high psychological distress were the least likely to use preventive 
behaviors as they relate to breast health. The authors conclude that being 
at high risk for breast cancer may not be a cue to action to initiate breast 
cancer screening. In fuct, it may increase a woman's level of fear to the 
point where it may act as a deterrent. Educational and psychological 
interventions should aim at reducing a woman's level of anxiety before 
they can be expected to engage in routine breast cancer surveillance. The 
authors also cautioned that the findings of this study should not be 
generalized beyond the study population because it included mostly white, 
well-educated, urban women. 
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The Impact of Family History of Breast Cancer on Women's Health 
Beliefs 
Finney and Iannotti (2001) incorporated components of the Health 
Belief Model into their investigation of differences in health beliefs 
between women with and without positive family histories of breast 
cancer. The researchers also expanded on the model to include issue 
involvement (defined previously) and salience of breast cancer family 
history as they relate to the use of mammography screening. The study 
population included primarily white women, over the age of forty, who 
were attending mammography screenings at a women's health clinic in 
Ohio. The sample size was 395 after excluding women under forty and 
women who did not complete the questionnaire. Women who reported 
having a least one first or second degree relative with breast cancer were 
classified as having a positive family history (n=159) and those who 
reported no family history were classified as having a negative family 
history (n=219). Women who were unaware of their family history 
(n=l7) were excluded from part of the analysis. The relative's age at 
breast cancer diagnosis was not addressed. The survey included questions 
about demographic characteristics, family history of breast cancer, and 
breast health behavior (i.e. BSE, CBE, and mammography). Questions 
assessing health belief variables focused on benefits and barriers to 
mammography screening, perceived susceptibility to developing breast 
cancer, perceived severity ofbreast cancer, and cues to action. Two scales 
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were developed to assess (1) the extent to which women's concerns about 
breast cancer were related to a personal family history of the disease and 
(2) issue involvement; which included things such as, frequency of 
worrying about the development of breast cancer, reading articles about 
breast cancer, and participation in fund- or awareness-raising activities. 
Bivariate analyses examined whether there were differences in 
responses based upon whether a woman had a negative or positive family 
history ofbreast cancer. Demographic variables were controlled for in a 
logistic regression model. Results showed that there were no significant 
differences between women with positive and negative family histories of 
breast cancer based on socio-demographic variables and breast health 
behaviors. However, some significant differences were obtained between 
women with and without a positive history for breast cancer (see Table 3). 
Women with a positive family history were more likely to perceive 
themselves as susceptible to developing breast cancer, had higher 
responses to cues to action regarding mammography, had higher levels of 
salience of family history, and showed greater levels of breast cancer issue 
involvement. 
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Table 3 
Differences in Mean and Standard Deviation (S.D.) of Health Beliefs for 
Women with Positive and Negative Family Histories of Breast Cancer 
Family History 
•••• ••••·-~·o•wo•-
Health Belief Component Positive Negative 
. ··--·· .............. ................... . M.e~~:PJ .. Me<lll.C~:P ,L 
Barrier 
Benefit 
Susceptibility 
Severity 
Cue to Act 
Salience of Family History 
Issue Involvement 
2.71 (.89) 2.63 (.89) 
6.11 (.88) 6.11 (.91) 
4.29 (1.26) 3.21 (1.13)* 
5.05 (.96) 4.98 (1.04) 
4.08 (1.17) 3.33 (1.02)* 
4.85 (1.96) 2.28 (1.19)* 
4.02 (1.09) 3.60 (1.08)* 
Note. *Means significantly different, P<O.OOl. 
Source: Finney & Iannotti (200 I). 
The findings from this study indicate that women with a family history 
of breast cancer view themselves as being much more susceptible to breast 
cancer than those with a negative history and they also are more 
responsive to cues to action. Both of these issues have important 
implications for health care providers. First, health care providers should 
be more sensitive to the idea that women with a positive family history of 
breast cancer may view themselves as being at higher risk for breast 
cancer. Secondly, these women may have a better response to reminder 
letters about mammography screening. 
The authors identified a few limitations of the study, however. The 
sample included a small number of minority women and included only 
women being screened by mammography. It would be important to 
17 
include other women in the population, since women already receiving 
~--
mammograms may be more health conscious. 
Relationships Among Objective and Subjective Risk for Breast Cancer and 
Mammography Stages of Change 
Lipkus, Rllner, and Strigo (1996) examined perceived risk in relation to 
stages of change. Their study had three objectives. The first was to 
examine the relationship between objective and subjective risk indices and 
screening patterns among women age 50 and older in a health 
maintenance organization. The second objective was to test whether 
objective and subjective risk predicted stages of change as defined by the 
Transtheoretical Model. Past studies have shown that higher pro and 
lower con decisional balance scores have been associated with the use of 
mammography screening (Rakowski, Fulton, & Feldman, 1993). 
Therefore, their third objective was to determine whether objective and 
subjective risk predicted stages of change in addition to decisional balance 
(i.e. the overall weighing of pros and cons). 
The study population was from the Kaiser Foundation Health Plan of 
North Carolina in the Research Triangle area. Medical records were 
reviewed and only women age 50 and above who had received two or 
fewer mammograms in a 36-month period were eligible. Of the 1913 
eligible women, 638 provided consent. From the 638 women, 486 (87% 
response rate) completed the baseline interview. These women were 
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contacted 3 months later to update information about mammography 
~-
screening and psychosocial variables related to mammography. 
Some of these women were dropped from the study due to death or illness, 
change in health insurance, and the lack of response to the 3-month 
survey. Analyses were based on the remaining 364 women with an 
average age of 58.4 years. Most were white (83%), married (83.2%), and 
had some college education (60.4%). None of these demographic 
variables affected the results significantly. Objective measures of risk 
were based on the Gail Model and the mean lifetime risk was 11.2%. 
Subjective risk was measured by asking the women what they thought 
their chances were of developing breast cancer in the next 10 years 
compared to other women their age. Next, stages of change for 
marumography were assessed and women were placed in the following 
categories; 1) precomtemplation (n=8), never had a mammogram and do 
not intend to, 2) relapse (n=33), have not had a mammogram in the past 
year and do not intend to in the next year, 3) relapse risk (n=29), have had 
a mammogram in the past year, but do not intend to have one the next 
year, 4) contemplators (n=86), have not had a mammogram in the past 
year, but intend to have one, 5) action (n=l03), have had a mammogram in 
the past year and plan to have one the next year, and 6) maintenance 
(n=105), have had at least one mammogram each year and plan to have 
another next year. 
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Overall, the majority of women assessed their comparative risk as less 
than average ( 40.1% ), or as average ( 43.4% ), with fewer women reporting 
higher than average risk (16.5%). Women reporting higher subjective risk 
were more likely to have a higher objective risk and women with family 
members who had breast cancer also were more likely to perceive 
subjective risk as being high. Table 4 provides an analysis of the 
subjective risk as a function of objective risk. 
Table 4 
Proportional Odds Regression Analyses Predicting Subjective Risk From 
Objective Risk Indices 
Model 
interval 
Overall objective risk 
Components of objective risk 
Number of relatives with 
breast cancer 
Number ofbreast biopsies 
Age at menarche 
Age at first live birth 
Odds Ratio 
2.74* 
5.94* 
1.28 
0.85 
0.88 
Note. *Means significantly different, P<O.OOL 
Source: Lipkus, Rimer, & Strigo (1996). 
95% confidence 
1.65-4.56 
2.91-12.11 
0.86-1.91 
0.60-1.23 
0.71-1.09 
The authors had predicted that women with higher subjective and 
objective risk would be more likely to be in the later stages of change for 
mammography screenings (e.g. action and maintenance). These 
predictions were supported. Women reporting a higher subjective risk 
were more likely to be ina later stage of change (OR 1.47, CI 1.13-1.91) 
and women who reported having family members with breast cancer, as a 
measure of objective risk, were also more likely to be in a later stage of 
change (OR 1.93, CI 1.01-3. 70). 
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Study findings show that a family history of breast cancer is the most 
salient feature among the objective components of risk. Also, both a 
higher subjective risk and fumily history ofbreast cancer were related to 
the later stages of change in regards to mammography use. Although the 
results showed a relationship between subjective and objective risk 
(women reporting high subjective risk also bad high objective risk), it was 
only modest and the correlation was only 0.21. The authors suggest that 
improvements should be made in risk communications, so that risk is more 
accurately perceived. Other physiological risk factors included in the 
objective risk did not predict subjective risk. Therefore, health care 
providers must educate women about these important risk factors, as well 
as the risk factor of family history of breast cancer. Since risk perceptions 
seem to have a great impact on screening behaviors, modifying them early 
may influence women in the precomtemplation and contemplation stages 
of mammography adoption (Lipkus, Rimer, & Strigo, 1996). 
The main limitation of this study is generalizability, given that the 
population was from an HMO. Women in this study were also mostly 
white, married and had college educations. Again, caution must be used 
when applying results to other groups of women. 
Younger Women at Increased Risk for Breast Cancer: Perceived Risk, 
Psychological Well-being, and Surveillance Behavior 
In 1994, Lerman, Kash, and Stefanek explored the relationship between 
psychological characteristics and surveillance behaviors of women under 
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the age of 50 who are at increased risk for breast cancer based on fumily 
history. To more fully evaluate these variables, the author's main 
objective was to compare risk perception, psychological symptoms, and 
surveillance patterns of women in different age groups. Study participants 
came from three major east coast cancer centers and analyses were 
provided for each site. 
The Fox Chase Cancer Center (FCCC) enrolled 179 females between 
the ages of30-75, who reported a history of breast cancer in at least oue 
frrst degree relative. There was a 98% response rate for a 15-minute 
telephone interview. The majority of the respondents were white (92%), 
and 37 %had an education beyond the high school level. There was a 
fairly equal proportion of women in the various age groups: ages 30-34 
[23%), ages 35-39 [26%], ages 40-49 [25%], and ages 50 and over [26%). 
About 9% of the women had more than one first-degree (FDR) relative 
with breast cancer, while 91% had only one FDR affected. The sample 
from the Johns Hopkins Oncology Center (JHOC) included 238 females 
between the ages of20-75, with a family history of breast cancer. Self-
report questionnaires were filled out prior to an initial visit at the Breast 
Surveillance Clinic by 70% of the women. The respondents were 
primarily white (96%) and had education beyond high school (61 %). The 
percentages of women in each age group are as follows: ages 20-29 
[18%], ages 30-34 [18%), ages 35-39 [17%], ages 40-49 [32%], and ages 
50 and over [16%]. Seventy nine percent had one FDR with breast cancer 
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and the remaining 21% had two or more FDR's with the disease. Of note, 
the women from these two centers were recruited through relatives who 
were breast cancer patients seen at the participating centers. The women 
in the third sample were from the Strang Cancer Prevention Center 
(SCPC) and they were all self-referred. The sample included 363 subjects, 
who were aged 20 and older and had a family history ofbreast cancer. 
The response rate for women who completed the self-report questionnaire 
was 73%. Again, the majority of respondents were white (90%), and 83% 
had education beyond high school. Percentages of women in each age 
group are as follows: ages 20-30 [7%], ages 30-34 [15%], ages 35-39 
[19%], ages 40-49 [33%], and ages 50 and over [26%]. Approximately 
one-third (34%) of the subjects had one FDR with bilateral premenopausal 
breast cancer, 45% had one affected FDR plus one affected second-degree 
relative, and 21% had two or more affected FDRs. 
The surveys consisted of a question that measured risk perception on a 
5-point scale, questions about time since last mammogram and frequency 
of breast self-examination (BSE), and questions about psychological 
symptoms. The BriefProfile ofMood States, The Mental Health 
Inventory and The Brief Symptom Index were used to measure 
generalized psychological distress. Different psychological scales were 
used in each clinic to evaluate symptoms specific for breast cancer risk. 
Basically, all three measured intrusive thoughts and worries about the risk 
for the development of breast cancer. 
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The results show that about two-thirds of women under 50 perceive 
themselves as being at high risk for breast cancer (see Table 5). About 
three fourths of women age 29 and younger believed that they would 
develop breast cancer someday. Women aged 30-34 and those aged 50 
and over in the FCCC sample, were less likely to perceive themselves as 
being at high risk than were women in other age groups. There were no 
age-related differences in risk perception among the women from JHOC 
and SCPC. Results for breast cancer surveillance practices (i.e., 
mammograms and BSE) are shown in Table 5. Interestingly, about 
one third of women aged 29 and younger in the JHOC and SCPC samples 
had obtained mammograms. Over three-fourths of all women studied over 
the age of35 had ever had a mammogram. Not shown in Table 5 are the 
proportions of women who reported having a mammogram within the past 
12 months. For women aged 29 and younger in the JHOC and SCPC 
samples, the percentages were between 14% and 31%, respectively, for 
having a mammogram in the past 12 months. For women between 30-34, 
the percentages ranged between 24-35% and for women between 35-39, 
the range was 40-50%. Women aged 40-49 from the SCCC sample had 
the highest percentage (82%) of reporting having a mammogram in the 
past year. For the other two samples of women in this same age group, the 
percentages were from 37-39%. In the women aged 29 and younger, 
almost three-fourths reported practicing BSE less often than once a month. 
The highest rates of nonadherence to monthly BSE were among women in 
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the SCPC sample. Of note, the women from the SCPC sample were all 
self-referred. 
Table 5 
Perceived Risk and Breast Screening Variables by Age Group for the 
Three Samples Studied by Lerman, et al. 
Age group, No. (%) 
Variable <30 30-34 35-39 40-49 >50 
Perceived risk 
Believe risk higher than 
~ 
27 (64) 38 (83) 
average* 
Believe likely to develop breast 30 (71) 34 (81) 31 (74) 
cancer+ 
Believe likely to develop breast 20 (77) 45 (79) 51 (75) 
cancer++ 
Mammography 
Ever had* 
~ 
24 (57) 35 (76) 
Ever had+ 13 (31) 36 (86) 41 (98) 
Ever had++ 9 (35) 39 (68) 58 (89) 
Breast self-examination 
Less than once/mo* 
~ 
14 (33) 5 (11) 
Once/mo 
~ 
12 (29) 26 (56) 
Greater than once/mo 
~ 
16 (38) 15 (33) 
Less than once/mo+ 22 (52) 18 (43) 17(41) 
Once/mo 17 (40) 19 (45) 14 (33) 
Greater than once/mo 3 (8) 5 (12) ]] (26) 
Less than once/mo++ 19 (74) 40 (71) 50 (74) 
Once/mo 3 (13) 14 (25) 15 (23) 
Great than once/mo 3 (13) 2 (4) I (3) 
Note: *FCCC, sample ofFDRs of breast cancer patients (n-179) 
+lliOC, sample ofFDRs of breast cancer patients (n=238) 
++SCPC, sample of self-referred breast cancer patients (n=363) 
Source: Lerman, Kash, & Stefanek (1994). 
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36 (80) 25 (54) 
59 (79) 26 (69) 
92 (77) 62 (65) 
40 (89) 40 (97) 
73 (97) 38 (100) 
101 9! (100) 
(100) 
17 (38) ]] (24) 
14 (31) 15 (32) 
14 (31) 2 (44) 
28 (37) 16 (43) 
35 (47) 17 (46) 
12 (16) 4(11) 
76 (63) 47 (49) 
37 (31) 40 (42) 
7 (6) 9 (9) 
Levels of depressive symptoms and mood disturbances in women from 
the JHOC and FCCC samples were comparable to those in the general 
population. Analysis of variance was used to evaluate general 
psychological measures in the SCCC sample and this method revealed that 
the highest levels of distress were among women aged 29 and younger (P 
= 0.002). With regard to specific worries about breast cancer, results from 
chi-square tests showed that the severity of worries among women in the 
JHOC sample did not vary by age group. Whereas, age-related effects 
were observed in the SCCC sample. The highest levels of worry that had 
an impact on daily functioning were observed in women within the 30-34 
(42%) and 50 and over (49%) age groups. The associations between 
psychological distress and surveillance practices varied by study 
population. In the FCCC sample, women who had not adhered to the age 
specific guidelines on mammography were shown to have higher intrusive 
thoughts about breast cancer (P =0.05). Women from this sample who 
practiced BSE more often than once per month were also more likely to 
have higher levels of intrusive thoughts about breast cancer (P = 0.008). 
This was in contrast to the women from the JHOC sample who had not 
had a mammogram in the past year. These particular women showed 
lower levels ofhreast cancer worries compared with women who had 
received a mammogram in the past year (P = 0.001). 
Given the fact that the majority of the women under 50 years of age 
thought their risk ofhreast cancer was above average is cause for concern. 
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Many women may be overestimating their actual risk of breast cancer. 
Therefore, it is important to educate women about their personal risks for 
breast cancer. In this sample, the majority of women aged 39 and younger 
had received mammograms. The authors alluded to the possibility that 
this is a higher figure than what would be found in the general population. 
They suggest that perceptions of vulnerability may be a stronger 
determinant of mammography use than objective risk status. 
According to the authors, these results are preliminary. The main 
limitations are due to variations between samples, because recruiting 
methods and risk profiles of the women were different. Also, some of the 
psychological measures differed among the study sites making it difficult 
to draw conclusions about associations that were obtained between 
psychological distress and surveillance measures. Finally, this population 
was homogeneous (Le., white and educated), so the results may not be 
generalizable to minority or less educated women. 
Perception of Breast Cancer Risk and Psychological Distress in Women 
Attending a Surveillance Program 
Gagnon, et al. (1996) hypothesized that women who had an inaccurate 
perception of breast cancer risk would have higher levels of psychological 
distress that would reduce adherence to breast cancer screening measures. 
The following three goals of the study were to: 1) evaluate the relationship 
between risk perception, psychological distress and adherence to breast 
self-examination (BSE); 2) investigate the impact of attending a 
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surveillance clinic on these three factors; and 3) pilot-test the efficacy of a 
mailed informational newsletter to improve patients' risk perception, 
reduce psychological distress and improve use ofBSE. 
Subjects were selected from the Memorial Sloan-Kettering Cancer 
Center Special Surveillance Breast Program (a program designed for 
women at high-risk for the development ofbreast cancer). They were 
accrued between March 1993 and March 1994. A total of 145 women 
were asked to participate in the study at the time of scheduling an initial 
appointment. If they agreed, they were mailed an informed consent and a 
self-administered questionnaire that took about 30 minutes to complete. 
Out of 145 women, 94 returned the questionnaires prior to their initial 
visit. The same questionnaires were sent out to these women at 2 and 
4 months after their initial visit. Various valid and reliable psychological 
instruments were used in the questionnaire, as well as questions about past 
psychiatric history, social support, and socio-demographics. Perception of 
risk was evaluated by asking women how they perceived their own risk 
and the risk of an average woman of developing breast cancer by two 
quantitative measures. One measure was based on percentage of risk and 
the other on a 1 0-cm visual analog scale that stated on one end, 'I have no 
chance at all' and at the other end was, 'I am absolutely certain to develop 
it.' General preventive health behaviors were measured with several 
reliable and valid items and additional questions were added about the 
practice ofBSE. 
28 
During the first visit to the surveillance program, women were asked to 
complete a questionnaire about family history of breast cancer, which was 
then reviewed with a breast surgeon. After a clinical breast exam (CBE) 
was performed and mammogram recommendations were reviewed, the 
breast surgeon also provided each woman with an estimate of personal 
risk for breast cancer based on both the Gail and Claus Empirical Risk 
Models. These risk couuseling sessions included information about risk 
factors for breast cancer and current methods used for early detection, 
which included BSE. 
Out of 82 women who returned their initial questionnaire prior to the l 
first appointment, 4 I were randomly selected to receive four issues of an I educational newsletter that included topics such as, usefulness of CBE, 
mammography and BSE, diet and cancer, and the role of a genetics 
couuselor in helping to determine breast cancer risk. The newsletters were 
sent out at different time points between entry into the program and 4 
months after entering the program. Of note, 12 women out of the original 
94 sent in the initial questionnaire after the randomization process and 
thus left 82 women for the intervention study. 
In terms of actual versus perceived risk, results show that the majority 
of women significantly overestimated their risk of developing breast 
cancer (see Table 6). The mean perception of risk was between 41 to 50 
percent on the categorical scale and 55% on the visual-analog scale. This 
was compared to actual mean risk based on the empirical risk estimate 
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models, which was 18% (P<0.001). Student t-tests were performed to 
compare continuous variables between and within subjects. 
Table 6 
Women's Perception of Their Risk ofDeveloping Breast Cancer Prior to 
the Initial Visit (n=94) 
Perception of risk 
Underestimation 
Accurate estimation 
Overestimation (at least doubled actual risk) 
Overestimation (less than double actual risk) 
Source: Gagnon, et al. (I 996). 
n 
4 
6 
71 
13 
% 
4 
6 
76 
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Forty-seven women did not feel confident in their ability to perfurm 
BSE and this was inversely correlated to a high perception of risk 
(P=0.001). More than half of the women performed BSE less often than 
monthly and only 15% performed BSE on a monthly basis. About one-
third reported performing BSE more often than once per month and 10% 
never performed BSE. There were no correlations between frequency of 
performing BSE and perception of risk, actual risk, social support or 
psychological distress. Over time, there was a significant decrease in 
women's perception of risk as assessed by the two subsequent 
questionnaires that were completed 2 and 4 months after the initial visit. 
At 4 months, the perception or risk reduction went from a 41-50% interval 
to a 31-40% interval (P=0.004) and on the visual analog scale it decreased 
from 54% to 45% (P=0.009). A reduction in cancer anxiety was also seen 
at the 4-month period (P<0.05). Over time, however, no significant 
changes were found in BSE performance. Finally, no significant 
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differences were seen between the women who received and did not 
receive the newsletter with respect to performance ofBSE, psychological 
distress, perception of risk or actual risk. 
One of the main study goals, determining whether attendance in a 
breast cancer surveillance program would have an impact on risk 
perception and psychological distress, was supported: reductions in risk 
perception and cancer anxiety were seen over time. However, there were 
no changes in the performance ofBSE. Although other researchers have 
found correlations between psychological distress and compliance with 
screening measures, this study found no correlations between anxiety, 
actual risk, perceived risk, family history ofbreast cancer and performance 
ofBSE. The authors speculate that perhaps an improvement in 
performance ofBSE may be seen over a longer period of time. This is 
based on the thought that a change in attitude usually comes before a 
change in actual behavior and many of the women in the study had 
reduced levels of anxiety over a 4-month period. The authors describe 
historical confounding as a potential reason why they did not see any 
difference in BSE performance rates between women who received the 
newsletters and those who did not. The newsletters were distributed at a 
time when there was substantial media coverage about problems with the 
National Surgical Adjuvant Breast Project trial and about the usefulness of 
mammograms. Women may have been more skeptical about breast cancer 
prevention and treatment during this time. Also, the newsletters provided 
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only general information on breast cancer risk as opposed to personalized 
information on risk, which may have led to the lack of effect from the 
newsletters. Evans et al. (1994) reported that women who received 
genetic counseling gave more precise personal risk estimations and were 
more likely to retain the information if they received it in a follow-up 
letter. This should be considered when designing psycho-educational 
materials for women attending a breast cancer surveillance program. 
Perceptions of Breast Cancer Risk, Objective Risk, and Adherence to 
Screening Measures in Women Attending a High-Risk Cancer Clinic- A 
Pilot Study 
Purpose of the Study 
My goal for this small descriptive pilot-study was to determine whether 
women attending a high-risk cancer clinic perceived their personal risks as 
being different than their calculated absolute risks. A secondary goal was 
to assess the level of adherence to screening measures (i.e. mammography, 
clinical breast exam [CBE], and breast self-examination [BSE]). 
Patient Selection 
Women for this pilot study were identified through the University of 
North Carolina's Comprehensive Cancer Center's High-Risk Clinic. 
Women were eligible if they did not have a personal history of breast 
cancer. After determining eligibility, a woman was then asked to 
participate in the study that involved completing a brief questionnaire (see 
Appendix A). Each woman read and signed an informed consent and was 
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given an opportunity to ask questions before filling out the questionnaire. 
Consent forms were prepared in accordance with the institution's internal 
review board (see Appendix B). Due to time limitations, only five women 
were approached about the study and all participated. Demographics L 
collected were for age and race only. The age range of these five 
women was from twenty-four through fifty-three, with a mean age of 40. 
One woman was African American and the other four were Caucasian. 
With regard to family history, each woman had at least one first-degree 
relative with a history of breast cancer. One woman had two first-degree 
relatives (mother and sister) with a history of breast cancer, as well as 
three second-degree relatives. Another woman had two relatives with 
both breast and ovarian cancer (mother and maternal aunt). These two 
later cases would suggest a strong family history of the disease. 
Measures 
Perception of risk was measured by two questions using a 5-point 
Likert scale. The first question asked about personal chance of 
developing breast cancer and the second asked about chance of dying from 
breast cancer. The responses ranged from not at all likely to extremely 
likely. Screening behaviors were assessed by "yes" and "no" questions on 
the use of mammography, CBE, and BSE. Additional questions were 
asked about time since last mammogram and CBE and about the 
frequency ofBSE practice. 
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Measurements of actual risk were calculated by the use of the 
BRCAPRO computer software package (University of Texas 
Southwestern Medical Center, 2000). This package includes computations 
of risk based on the Gail and Claus empirical risk models. Both of these 
models predict lifetime risks for developing breast cancer by calculating 
percentages. Additionally, the software provides calculations for 
estimating probabilities of carrying a mutation in the BRCAl and/or 
BRCA2 genes. 
Results 
Most of the women felt that their chances of developing breast cancer 
were either somewhat likely or likely, with ouly one participant choosing 
very likely as her response. None of the participants chose not at all likely 
or extremely likely for this question. The responses for the question about 
personal chance of dying from breast cancer were mostly somewhat likely, 
with ouly one woman choosing not all likely and one woman chose very 
likely. The woman who felt that her chances of developing breast cancer, 
and also of dying from breast cancer, were very likely had two relatives 
with both breast and ovarian cancer. One of the relatives was the 
participant's mother who was diagnosed with breast cancer at age forty-
five and she died at age fifty-five. When perception of risk, based 
solely on a qualitative scale, was compared to actual mean risk(%) for 
each woman, it appeared that none of the women underestimated or 
overestimated their risk substantially (see Table 7). Only the study 
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participant, who had the two relatives with the diagnoses of breast and 
ovarian cancer, had a high probability for carrying a BRCA mutation. Her 
carrier probability for a BRCA1 mutation was 49% and for a BRCA2 
mutation it was less than one percent. Since none of the other women had 
any significant chance of carrying a BRCAl or BRCA2 mutation, their 
percentages are not reported in this paper. 
Table 7 
Comparison ofWornen's Perception ofRisk with their Actual Risk(%) 
Based on the Gail and Claus Models of Breast Cancer Risk Assessment 
·-··-· -~---··· -~ ..~ ...-........... -.. ~=-.-..... -..... -.... ~ .. = ... -... -... -...... ·=·· ·-··""···""·· .......... = ... -........ ··""···= ..... - .. -. -~--· .. ···-··········· .. •• Qllt:~!i()lJ:.. ................ .. Re_sE()[lSeS . ..-.Cili~('lfo) ClJl.llsJ%) 
Chances of developing 
breast cancer? 
Subject #1 
Subject #2 
Subject#3 
Subject #4 
Subject #5 
Very likely 
Likely 
Somewhat likely 
Likely 
Somewhat likely 
25.6% 37.7% 
20.8% 30.2% 
15.9% 8.8% 
16.5% 17.7% 
24.2% 16.5% 
With regard to screening behaviors, all but one subject reported, ''yes" 
for ever having a mammogram and they were all within the past two year 
period. The one woman who never had a mammogram reported that she 
had a prophylactic bilateral mastectomy based on her strong family history 
of breast cancer. She did however continue to examine the area where her 
breasts were excised. All five of the women had CBE's performed within 
the last two years and only two women performed BSE monthly. Results 
for screening behaviors for each subject are shown in Table 8. 
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Table 8 
Breast Cancer Screening Behaviors for Each Subject 
Question Subject Subject Subject Subject Subject 
#1 #2 #3 #4 #5 
Ever had a No Yes Yes Yes Yes L 
mammogram? 
How long NA Less than Less than 1-2 years Less than 
since your last I year 1 year 1 year 
mammogram? 
Ever had a clinical Yes Yes Yes Yes Yes 
breast exam? 
How long since Less than Less than Less than 1-2years Less than 
last clinical hreast I year I year I year 1 year 
exam? 
Do you practice Yes Yes Yes No Yes 
hreast self-examination? 
How often do you Once a Less than Less than NA Once a 
perform hreast self- month once/roo once/mo month 
examination? 
Note: NA mdiCates not applicable. 
Discussion 
Although it is somewhat difficult to compare qualitative statements 
about breast cancer risk perception with quantitative risk calculations, 
some helpful information can still be derived. From this very small 
sample, it appears that none of the women grossly overestimated or 
underestimated their chances of developing breast cancer. Study 
participant #I felt that her chances of developing breast cancer were very 
likely and her actual risk based on the two models is between 25 and 35 
percent over her lifetime. This is substantially higher than for women in 
the general population. The general population risk is approximately 12 
percent, as stated earlier. Study participant #3 had an actual risk of 
between 8 and 15 percent and she felt that her chances of developing 
breast cancer were somewhat likely. Other studies have shown that as 
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many as half of the women with a family history of breast cancer tend to 
overestimate their risks (Lerman, Kash, & Stephanek 1994; Lerman & 
Schwartz, 1993). In retrospect, it would have been preferable to assess 
perceived risk using a percentage scale. This would have allowed for a 
more accurate comparison with actual individual risks that are expressed 
as percentages. It is possible that the majority of women would be 
overestimating personal risk if measurements were made on a percentage 
scale. 
All but one of the women had a mammogram and all were performed 
within the last 1-2 year period prior to the study. Study participant #1 
never had a mammogram, but had a CBE in the last year and had 
undergone a bilateral mastectomy as was mentioned earlier. The other 
four women had CBE's in the past 1-2 year period, with most of them 
occurring in less than one year. Only one woman did not perform BSE at 
all and two women performed BSE less than once a month. In general, 
these women with family histories of breast cancer were adhering to 
screening measures for breast cancer with regard to mammography and 
CBE's. A few of the women were not following the often recommended 
monthly BSE, despite their higher than average risk for breast cancer. 
This pilot study only provides some preliminary data on a very small 
study population of women seeking counseling at a high-risk cancer clinic. 
Suggestions for improved study design are: 1) Increasing the number of 
women in the study so that statistical analyses can be performed, 2) Alter 
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the questionnaire so that it includes a quantitative rating scale for personal 
risk perception and a question about comparative risk with the general 
population, 3) Administer the same questionnaire post-counseling and 
compare it with the pre-counseling questionnaire, and 4) Perform an 
educational intervention trial that provides a how to fuct sheet on BSE, 
information on diet and exercise as they relate to breast cancer, 
information about individual risk factors and analysis of risk estimates, 
and stresses the importance of screening measures. The intervention 
should also include a demonstration ofBSE by a health professional, 
along with a self-demonstration by the study participant. An improved 
study design can help answer the question about whether certain 
interventions can lead to more accurate risk perceptions by women with 
family histories of breast cancer. Additionally, valuable information may 
be gained about whether or not an educational intervention improves 
adherence to screening measures. 
Conclusions 
There are a considerable number of women in this country who have a 
family history of breast cancer. Many of these women tend to 
overestimate their own personal risk for developing breast cancer, which 
in some cases can lead to psychological distress and may alter a woman's 
use of screening measures. It is, therefore, very important that health care 
professionals recognize these disparities when counseling and educating a 
woman with a fumily history of breast cancer. Risk models, such as the 
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Gail and Claus Risk Estimation Models, can provide helpful information 
to the clinician and patient. Used correctly, they can help a woman 
understand her risk and also aid in the decision-making processes about 
genetic testing and/ or prophylactic strategies. A more accnrate perception 
of risk may lead to a reduction in psychological distress and possibly 
improve adherence to breast cancer screening measnres. Educational 
interventions have been found to improve risk perception when a post-
counseling letter included information on precise personal risk estimations 
(Evans, eta!., 1994). Also, Lerman and others (1992) found that the use 
of a psychoeducational booklet, focusing on mammography adherence, 
leads to greater annual mammography use. Rimer and Glassman (1999) 
have suggested that tailored print communications (TPCs) may show great 
promise as an aid to communicate cancer risk. TPCs are written materials 
that provide information that is specific for each individual based on his or 
her own risk factors. Evans and others (1994) used a similar strategy, but 
TPCs can include much more information on risk factors and on screening 
methods. It is likely that more studies will utilize these TPCs when 
attempting to improve not only risk perception, but adherence to screening 
measnres as well. The hope for the futnre is that women with a family 
history of breast cancer will have more accnrate perceptions of personal 
risk and increase their adherence to screening measnres after attendance at 
high-risk cancer clinics or breast cancer surveillance clinics. The use of 
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TPCs in these clinics may be the best intervention to evaluate in future 
studies. 
i 
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Appendix A 
PERCEIVED RISK OF DEVELOPING BREAST CANCER AND 
SCREENING BEHAVIORS QUESTIONNAIRE 
Please circle only ONE answer 
L What do you believe your chances are of developing breast cancer? 
Not at all likely Somewhat likely Likely Very likely Extremely likely 
2. What do you believe your chances are of dying from breast cancer? 
Not at all likely Somewhat likely Likely Very likely Extremely likely 
3. Have you ever had a mammogram? 
Yes No 
4. If "yes", how long has it been since your last mammogram? 
Less than I year I to 2 years More than 2 years Not sure 
5. Have you ever had a clinical breast exam? 
Yes No 
6. lf"yes", how long has it been since your last clinical breast exam? 
Less than I year I to 2 years More than 2 years Not sure 
7. Do you practice Breast Self-Examinations (BSE)? 
Yes No 
8. If ''yes", how often do you perform BSE? 
Less often than once a month Once a month More than once a month 
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AppendixB 
University of North Carolina-Chapel Hill 
Consent to Participate in a Research Questionnaire 
Title of Questionnaire: Perceived Risk of Developing Breast Cancer and 
Screening Behaviors 
Principle Investigator: Denise Spector, ARNP, MSN, MPH candidate 
UNC-CH Department: School ofPublic Health- Public Health Leadership 
Phone number: 919-929-1949 
You are being asked to take part in a research study. The investigator listed 
above is in charge of the study; other professional persons may be helping. 
What are some general things you should know about research studies? 
Research studies are designed to gain knowledge that may help other people 
in the future. You may not receive any direct benefit from participating. 
There may also be risks associated with participating in research studies. 
Your participation is voluntary. You may refuse to participate, or may 
withdraw your consent to participate in any study at any time, and for any 
reason, without jeopardizing your future care at this institution or your 
relationship with your doctor. If you are a patient with an illness, you do not 
have to participate in research in order to receive treatment. 
Details about this particular study are discussed below. It is important that 
you understand this information so that you can decide in a free and informed 
manner whether you want to participate. You will be given a copy of tbis 
consent form. You are urged to ask the investigator named above any 
questions you have about this study at any time. 
What is the purpose ofthis study? 
To examine the relationship between a woman's perceived risk of developing 
breast cancer and her actual relative risk, as well as assess breast cancer 
screening practices. You have been invited to participate since you are a 
patient in the cancer high-risk clinic and you do not have a personal history of 
breast cancer. 
How many subjects will participate in this study? 
A total of approximately 25 women from tbis institution will participate in this 
study. 
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How long will your participation last? 
Approximately 5 minutes to complete a questionnaire. 
What is required of participants? 
The completion of a one time questionnaire. 
Are there any reasons you should not participate? 
If you have a personal history of breast cancer. 
What are the possible risks or discomforts? 
You may feel sad or worried when you are asked about your personal risk of 
developing breast cancer. 
What are the possible benefits? 
There are no direct health benefits to you from participating in this survey. 
However, future patients may benefit from a better understanding about 
individuals' beliefs about developing breast cancer and the use of breast 
cancer screening measures. 
How will your privacy be protected? 
All information collected will be kept secured by the principle investigator 
and questionnaire data will only be identified with a study code that cannot be 
traced to you. No participants will be identified in any report or publication 
about this questionnaire. 
Will you be paid for participation? 
There is no financial compensation for participation in this study. 
Will it cost you anything to participate? 
There will be no cost to you for your participation. 
Voluntary Participation 
Again, your participation in this survey is voluntary. You will continue to 
receive your usual medical care regardless of whether or not you decide to 
participate in this survey. 
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What if you have questions about this study? 
You have the right to ask, and have answered, any questions you may have 
about this research. If you have further questions, you should call Denise 
Spector, ARNP, MSN at 919-929-1949 or James Evans, MD, PhD at 919-
966-2276. We value your consideration for taking part in this survey. 
Participants Statement 
I have read the information provided and have had the opportunity to ask 
questions about this survey. These questions have been answered to my 
satisfuction. My signature below indicates my voluntary participation in this 
survey. 
Signature of participant Printed name Date 
Research Personnel Statement 
I have provided an explanation of the above research study. The participant 
was given an opportunity to discuss the study and to ask questions. A signed 
copy of the consent will be given to the participant. 
Signature Date 
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